Roche Holding Ltd - Net Worth and Insider Trading

Roche Holding Ltd Net Worth

The estimated net worth of Roche Holding Ltd is at least $196 Million dollars as of 2024-12-27. Roche Holding Ltd is the 10% Owner of Pandion Therapeutics Inc and owns about 3,086,084 shares of Pandion Therapeutics Inc (PAND) stock worth over $185 Million. Roche Holding Ltd is the 10% Owner of Jasper Therapeutics Inc and owns about 454,961 shares of Jasper Therapeutics Inc (JSPR) stock worth over $10 Million. Roche Holding Ltd is also the 10% Owner of Aileron Therapeutics Inc and owns about 35,118 shares of Aileron Therapeutics Inc (ALRN) stock worth over $79,016. Details can be seen in Roche Holding Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Roche Holding Ltd has not made any transactions after 2023-01-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Roche Holding Ltd

To

Roche Holding Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Roche Holding Ltd owns 9 companies in total, including Pandion Therapeutics Inc (PAND) , Spark Therapeutics Inc (ONCE) , and Foundation Medicine Inc (FMI) among others .

Click here to see the complete history of Roche Holding Ltd’s form 4 insider trades.

Insider Ownership Summary of Roche Holding Ltd

Ticker Comapny Transaction Date Type of Owner
PAND Pandion Therapeutics Inc 2020-07-21 10 percent owner
ONCE Spark Therapeutics Inc 2019-12-17 10 percent owner
FMI Foundation Medicine Inc 2018-07-31 director & 10 percent owner & other: See footnote (1)
LIMIT LIMIT 2018-07-18 10 percent owner
LIMIT LIMIT 2017-07-05 10 percent owner
LIMIT LIMIT 2016-03-17 10 percent owner
LIMIT LIMIT 2021-10-28 10 percent owner
LIMIT LIMIT 2023-01-25 10 percent owner
LIMIT LIMIT 2023-10-25 10 percent owner

Roche Holding Ltd Latest Holdings Summary

Roche Holding Ltd currently owns a total of 3 stocks. Among these stocks, Roche Holding Ltd owns 3,086,084 shares of Pandion Therapeutics Inc (PAND) as of July 21, 2020, with a value of $185 Million and a weighting of 94.73%. Roche Holding Ltd owns 454,961 shares of Jasper Therapeutics Inc (JSPR) as of January 25, 2023, with a value of $10 Million and a weighting of 5.23%. Roche Holding Ltd also owns 35,118 shares of Aileron Therapeutics Inc (ALRN) as of July 5, 2017, with a value of $79,016 and a weighting of 0.04%.

Latest Holdings of Roche Holding Ltd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PAND Pandion Therapeutics Inc 2020-07-21 3,086,084 60.05 185,319,344
JSPR Jasper Therapeutics Inc 2023-01-25 454,961 22.50 10,236,623
ALRN Aileron Therapeutics Inc 2017-07-05 35,118 2.25 79,016

Holding Weightings of Roche Holding Ltd


Roche Holding Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Roche Holding Ltd has made a total of 1 transactions in Pandion Therapeutics Inc (PAND) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pandion Therapeutics Inc is the acquisition of 36,111 shares on July 21, 2020, which cost Roche Holding Ltd around $649,998.

According to the SEC Form 4 filings, Roche Holding Ltd has made a total of 1 transactions in Jasper Therapeutics Inc (JSPR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Jasper Therapeutics Inc is the sale of 7,500 shares on January 25, 2023, which brought Roche Holding Ltd around $141,750.

According to the SEC Form 4 filings, Roche Holding Ltd has made a total of 0 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 5,970 shares on July 5, 2017, which cost Roche Holding Ltd around $2 Million.

Insider Trading History of Roche Holding Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Roche Holding Ltd Trading Performance

GuruFocus tracks the stock performance after each of Roche Holding Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roche Holding Ltd is -10.18%. GuruFocus also compares Roche Holding Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roche Holding Ltd within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Roche Holding Ltd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Roche Holding Ltd

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.22 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.28 LIMIT LIMIT LIMIT LIMIT LIMIT

Roche Holding Ltd Ownership Network

Ownership Network List of Roche Holding Ltd

No Data

Ownership Network Relation of Roche Holding Ltd

Insider Network Chart

Roche Holding Ltd Owned Company Details

What does Pandion Therapeutics Inc do?

Who are the key executives at Pandion Therapeutics Inc?

Roche Holding Ltd is the 10 percent owner of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Mva Investors, Llc , and 10 percent owner Polaris Partners VIII, L.P. .

Pandion Therapeutics Inc (PAND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Pandion Therapeutics Inc Insider Transactions

No Available Data

Roche Holding Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Roche Holding Ltd. You might contact Roche Holding Ltd via mailing address: Roche Holding, Ltd., Grenzacherstrasse 124, Basel V8 Ch-4070.

Discussions on Roche Holding Ltd

No discussions yet.